Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
3(60.0%)
Phase 1
2(40.0%)
5Total
Phase 2(3)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07028749Phase 2Recruiting

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Role: lead

NCT07641179Phase 2Not Yet Recruiting

A Study to Evaluate MAR002 for Acromegaly

Role: lead

NCT07195175Phase 1Recruiting

Study of MAR002 in Healthy Men

Role: lead

NCT05896254Phase 1Completed

Study of MAR001 in Adults With Metabolic Dysfunction

Role: lead

NCT07199309Phase 2Recruiting

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Role: lead

All 5 trials loaded